You are here Home Resources and guidance Sponsors BeiGene AUS Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Designation or determination (1) Prescription medicine registration (1) Date (-) 2023 (2) 2025 (3) 2024 (5) 2022 (3) 2021 (5) 2020 (1) Search Filters applied:2023Clear all Sponsor content2 result(s) found, displaying 1 to 2 Notice for tislelizumab (Beigene Aus Pty Ltd) 23 October 2023 Designation or determination Orphan drug BRUKINSA (Beigene Aus Pty Ltd) 1 March 2023 Prescription medicine registration Active ingredients: zanubrutinib.
Notice for tislelizumab (Beigene Aus Pty Ltd) 23 October 2023 Designation or determination Orphan drug
BRUKINSA (Beigene Aus Pty Ltd) 1 March 2023 Prescription medicine registration Active ingredients: zanubrutinib.